Large-scale testing (Phase 3)Study completedNCT00838357
What this trial is testing
A Multi-centre, Open Label, Single-arm Study Intended to Further Investigate the Safety and Efficacy of Plerixafor as a Front-line Mobilisation Agent in Combination With G-CSF in Patients With Lymphoma or MM (Multiple Myeloma).
Who this might be right for
Lymphoma (Non-Hodgkin's Lymphoma)Hodgkin's Disease or Multiple MyelomaFront Line Mobilization+1 more
Genzyme, a Sanofi Company 118